Tempsens Instruments made a blockbuster debut on the Indian stock market after its shares listed at ₹634, delivering a 111.33% premium over the ₹300 IPO price. The debut ended a 609-day wait for a mainboard IPO to more than double investors’ money on listing day.
टैग: IPO 2026
Symbiotec Pharmalab IPO Day 4: GMP at 29%, Should You Subscribe?
Symbiotec Pharmalab IPO has entered its final bidding day with the issue subscribed 5.31 times and the grey market premium indicating a potential 29% listing gain over the upper price band.
Hy-Tech vs Symbiotec vs Skyways: Which IPO Signals the Biggest Listing Gain?
Hy-Tech Engineers is leading the three IPOs in grey market premium terms after Day 3, with an implied 75.47% listing gain, ahead of Symbiotec Pharmalab and Skyways Air Services.
Hy-Tech Engineers IPO Sees 51x Demand as GMP Hits 57%
Hy-Tech Engineers IPO has drawn strong investor interest on Day 3, with the issue subscribed 51 times and the grey market premium indicating a potential 57% premium over the upper price band.
Upcoming IPOs Next Week: 9 Issues to Open
New Delhi, India — The Indian IPO market is set for another busy week, with nine public issues scheduled to open and eight companies lined up for stock-market listings, according to the supplied market schedule. The upcoming IPOs include Hy-Tech Engineers, Skyways Air and Symbiotec Pharmalab, while the broader primary-market activity comes as Indian equities ended lower for a second consecutive week.
Manipal Health IPO Opens: ₹9,275 Crore Issue, GMP, Allotment and Listing Details
Manipal Health IPO opened for public subscription on Wednesday, July 29, 2026, with Manipal Health Enterprises Ltd seeking to raise around ₹9,275 crore through its maiden public offering. The Bengaluru-based hospital chain, backed by Temasek and Ranjan Pai, has launched one of the largest healthcare IPOs in the Indian primary market. The three-day issue will remain open until July 31.